The DrugMonkey blogger, who apparently works for NIH or another US government agency, says that the method for deciding on the order in which authors are listed on papers needs to be revised. PIs are always last, leaving everyone who did the heavy lifting vying for the coveted first-author position, according to the post. DrugMonkey's proposal: let reviewers flag which parts of the paper are most important, and then assign authorship order based on who contributed to those key parts.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Direct-to-consumer genetic testing companies have offered to test families separated at the southern US border, but that raises ethical issues.

CNBC reports that confirming a positive result from 23andMe's BRCA health report can be expensive.

The New York Times reports on a project to develop a tree DNA database to uncover illegal logging.

In PLOS this week: links between gut microbiome and colorectal cancer mutations, targeted sequencing uncovers genetic susceptibilities to epilepsy in Koreans, and more.